Biotech Intensity Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update August 9, 2024
Biotech Abzena Supplies Clinical Trial Material for Angiex’s Phase I Study of AGX101, a First-in-Class TM4SF1-directed ADC August 9, 2024
Biotech Regulus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Updates August 9, 2024
Biotech Biohaven Reports Second Quarter 2024 Financial Results and Recent Business Developments August 9, 2024
Biotech WuXi Biologics and Medigene Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell Engagers August 8, 2024
Biotech WestGene to Advance Clinical Trials Following Dual IND Approvals for World’s First EB Virus-Related mRNA Therapeutic Cancer Vaccine August 8, 2024
Search
Biotech
August 10, 2024
August 10, 2024
August 10, 2024
August 9, 2024
August 9, 2024
August 9, 2024
August 9, 2024
August 9, 2024
August 8, 2024
August 8, 2024
